➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Baxter
McKesson
Medtronic
Harvard Business School
McKinsey

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

HYDROCORTISONE VALERATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Hydrocortisone Valerate patents expire, and what generic alternatives are available?

Hydrocortisone Valerate is a drug marketed by Cosette, Glenmark Pharms Ltd, Lupin Ltd, Perrigo Israel, Taro, and Fougera Pharms. and is included in nine NDAs.

The generic ingredient in HYDROCORTISONE VALERATE is hydrocortisone valerate. There are sixty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrocortisone valerate profile page.

US ANDA Litigation and Generic Entry Outlook for Hydrocortisone Valerate

A generic version of HYDROCORTISONE VALERATE was approved as hydrocortisone valerate by TARO on August 25th, 1998.

  Start Trial

US Patents and Regulatory Information for HYDROCORTISONE VALERATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 074489-001 Aug 12, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Fougera Pharms HYDROCORTISONE VALERATE hydrocortisone valerate OINTMENT;TOPICAL 075085-001 Jul 31, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo Israel HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 075666-001 May 24, 2000 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Pharms Ltd HYDROCORTISONE VALERATE hydrocortisone valerate OINTMENT;TOPICAL 211750-001 Dec 14, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Pharms Ltd HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 211129-001 Oct 12, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin Ltd HYDROCORTISONE VALERATE hydrocortisone valerate CREAM;TOPICAL 210307-001 Aug 15, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Mallinckrodt
Medtronic
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.